StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Eli Lilly (LLY) PT Lowered to $124 at BMO Capital
November 7, 2018 12:40 PM
BMO Capital analyst Alex Arfaei lowered the price target on Eli Lilly (NYSE: LLY) to $124.00 (from $130.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS View
Analyst PT Change
Next Articles
Eli Lilly (LLY) PT Raised to $106 at Societe Generale
November 7, 2018 3:01 AM
Form 4 LILLY ELI & CO For: Nov 03 Filed by: Norton Johna
November 6, 2018 1:26 PM
Form 10-Q LILLY ELI & CO For: Sep 30
November 6, 2018 10:37 AM
Lilly to consider more acquisitions like $1.6 billion Armo buy
November 6, 2018 9:02 AM
Form 8-K LILLY ELI & CO For: Nov 06
November 6, 2018 7:04 AM
Trulicity leads mixed third quarter for Lilly; shares sink
November 6, 2018 6:37 AM
Eli Lilly & Co. (LLY) Tops Q3 EPS by 4c, Raises FY EPS Guidance
November 6, 2018 6:26 AM
Lilly Delivers Solid Third-Quarter 2018 Results, Revises EPS Guidance
November 6, 2018 6:25 AM
